Ppt chapter 30-1
-
Upload
stanbridge -
Category
Documents
-
view
98 -
download
0
description
Transcript of Ppt chapter 30-1
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Adrenergic AgonistsAdrenergic Agonists
Chapter 30
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Adrenergic AgonistsAdrenergic Agonists
• Definition
– Called sympathomimetic drugs because they mimic the effects of the sympathetic nervous system (SNS)
• Therapeutic and Adverse Effects
– Related to their stimulation of adrenergic receptor sites
• Uses
– Varies from ophthalmic preparations for dilating pupils to systemic preparations for shock
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Physiological Responses of Adrenergic Agonists
Physiological Responses of Adrenergic Agonists
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Alpha- and Beta-Adrenergic Agonists and Their Indications
Alpha- and Beta-Adrenergic Agonists and Their Indications
• Epinephrine (Adrenalin, Sus-Phrine): Shock; glaucoma; prolongs effects of regional anesthetic
• Norepinephrine (Levophed): Treat shock or during cardiac arrest to get sympathetic activity
• Dopamine (Intropin): Shock
• Dobutamine (Dobutrex): Congestive heart failure
• Ephedrine (Pretz-D): Seasonal rhinitis; hypotensive episodes
• Metaraminol (Aramine): Synthetic agent that is similar to norepinephrine
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Alpha- and Beta-Adrenergic AgonistsAlpha- and Beta-Adrenergic Agonists
• Actions
– The effects of these drug are mediated by the adrenergic receptors in target organs; heart rate increases, bronchi dilate, vasoconstriction occurs, intraocular pressure decreases, glycogenolysis occurs throughout the body
• Indications
– Treatment of hypotensive shock, bronchospasm, and some types of asthma
• Pharmacokinetics
– Rapidly absorbed after injection or passage through mucous membranes
– Metabolized in the liver and excreted in the urine
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Alpha- and Beta-Adrenergic Agonists (cont.)
Alpha- and Beta-Adrenergic Agonists (cont.)
• Contraindications
– Pheochromocytoma
– Tachyarrhythmias or ventricular fibrillation
– Hypovolemia
– Halogenated hydrocarbon general anesthetics
– Caution should be used with peripheral vascular disease
• Caution
– PVD
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Alpha- and Beta-Adrenergic Agonists (cont.)
Alpha- and Beta-Adrenergic Agonists (cont.)
• Adverse Reactions
– Arrhythmias, hypertension, palpitations, angina, dyspnea
– Nausea and vomiting
– Headache and sweating
• Drug-to-Drug Interaction
– Tricyclic antidepressants and MAOI’s
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Alpha-Specific Adrenergic Agonists (Alpha-Agonists)
Alpha-Specific Adrenergic Agonists (Alpha-Agonists)
• Definition
– Drugs that bind primarily to alpha-receptors rather than to beta-receptors
• Drugs In This Class
– Phenylephrine (Neo-Synephrine, Allerest, AK-Dilate, and others)
– Midodrine (ProAmantine)
– Clonidine (Catapres)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Alpha-Specific Adrenergic Agonists (Alpha-Agonists) (cont.)
Alpha-Specific Adrenergic Agonists (Alpha-Agonists) (cont.)
• Actions
– Therapeutic effects come from the stimulation of alpha-receptors within the SNS
• Indications
– Hypertension, constriction of topical vessels in nose
• Pharmacokinetics
– Well absorbed and reach peak levels in a short period—20 to 45 minutes
– Widely distributed in the body
– Metabolized in the liver and excreted in the urine
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Alpha-Specific Adrenergic Agonists (Alpha-Agonists) (cont.)
Alpha-Specific Adrenergic Agonists (Alpha-Agonists) (cont.)
• Contraindications
– Allergy to drug
– Severe hypertension or tachycardia
– Narrow-angle glaucoma
– Pregnancy
• Caution
– CVD or vasomotor spasm
– Thyrotoxicosis or diabetes
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Alpha-Specific Adrenergic Agonists (Alpha-Agonists) (cont.)
Alpha-Specific Adrenergic Agonists (Alpha-Agonists) (cont.)
• Adverse Reactions
– Anxiety, restlessness, depression, fatigue, blurred vision
– ECG changes, arrhythmias, blood pressure changes
– Nausea, vomiting
– Decreased urinary output
• Drug-to-Drug Interaction
– MAOIs and TCAs
– Digoxin and beta-blockers
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
QuestionQuestion
Please identify the following statement as true or false.
Another name for an adrenergic agonist drug is a sympathomimetic drug.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AnswerAnswer
True
Rationale: An adrenergic agonist is also called a sympathomimetic drug because it mimics the effects of
the sympathetic nervous system (SNS).
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Beta-Specific Adrenergic Agonists and Their Indications
Beta-Specific Adrenergic Agonists and Their Indications
• Isoproterenol (Isuprel)
– Treatment of shock, cardiac standstill, and heart block in transplanted hearts; prevention of bronchospasm during anesthesia; inhaled to treat bronchospasm
• Ritodrine (Yutopar)
– Management of preterm labor
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Beta-Specific Adrenergic AgonistsBeta-Specific Adrenergic Agonists
• Actions
– Effect is related to its stimulation of the beta-adrenergic receptors
– Increase heart rate, conductivity, and contractility, bronchodilation, increase blood flow to skeletal muscles and splanchnic bed, and relaxation of uterus
• Pharmacokinetics
– Rapidly distributed after injection
– Metabolized in the liver and excreted in the urine
– T ½ less than 1 hour
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Beta-Specific Adrenergic Agonists (cont.)Beta-Specific Adrenergic Agonists (cont.)
• Contraindications
– Allergy
– Pulmonary hypertension
– Eclampsia, uterine hemorrhage, and intrauterine death
– Pregnancy and lactation
• Caution
– Diabetes, thyroid disease
– Vasomotor problems
– Heart disease and stroke
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Beta-Specific Adrenergic Agonists (cont.)Beta-Specific Adrenergic Agonists (cont.)
• Adverse Reactions
– Restlessness, anxiety, and fear
– Tachycardia, angina, MI, and palpitations
– Difficulty breathing, cough, and bronchospasm
– Nausea, vomiting, and anorexia
• Drug-to-Drug Interaction
– Increase with other sympathomimetic drugs
– Decrease with beta adrenergic blockers
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Use of Adrenergic Agents Across the Lifespan
Use of Adrenergic Agents Across the Lifespan
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Alpha- and Beta-Adrenergic Agonists
Prototype Alpha- and Beta-Adrenergic Agonists
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Alpha-AgonistsPrototype Alpha-Agonists
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Beta-Specific Adrenergic Agonists
Prototype Beta-Specific Adrenergic Agonists
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Alpha- and Beta-Adrenergic Agonists
Nursing Considerations for Alpha- and Beta-Adrenergic Agonists
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Alpha-Agonists
Nursing Considerations for Alpha-Agonists
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Beta-Specific Adrenergic Agonists
Nursing Considerations for Beta-Specific Adrenergic Agonists
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
QuestionQuestion
When providing care for a patient receiving alpha and beta adrenergic agonists, which of the following would be important to assess in order to prevent the systemic overload of catecholamines?
A. Hypotension
B. Pheochromocytoma
C. Hypovolemia
D. Allergic rhinitis
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AnswerAnswer
B. Pheochromocytoma
Rationale: Assess for contraindications or cautions including pheochromocytoma which could lead to fatal reactions
due to systemic overload of catecholamines.